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Ashbya gossypii is a filamentous Saccharomycete long known by the scientific and industrial 
communities, first as a cotton pathogen and subsequently as a riboflavin overproducer. Its industrial 
relevance combined with its high genetic similarity with Saccharomyces cerevisiae promoted the 
development of a significant molecular and in silico toolbox for its genetic engineering. This, together 
with the increasing knowledge of its genome, transcriptome and metabolism has helped designing 
effective metabolic engineering strategies for optimizing riboflavin production, and also for developing 
new A. gossypii strains for novel biotechnological applications [1]. Here, we will address our main 
contributes for the development of A. gossypii as a cell factory organism, by presenting an overview of 
the most representative outputs from our research [referenced in 1, 2].  
Envisioning its exploration as a recombinant protein producer, our main efforts focused on the 
characterization of the A. gossypii protein secretory pathway at the genomic, transcriptomic and 
proteomic levels [2]. Based on experimental observations and on data from omic analyses, a hydrolytic 
enzyme, invertase, was deduced to be natively secreted by A. gossypii and molecularly characterized. 
The N-glycosylation pattern of the proteins natively secreted by A. gossypii was also characterized, as 
well as the recombinant production by this fungus of secreted proteins from different fungal origins. 
Among these, the β-galactosidase from Aspergillus niger was expressed in A. gossypii under the 
regulation of several native and heterologous promoters, presenting the highest extracellular production 
levels.  
A new molecular tool based on the Cre-loxP recombination system was also developed for generating 
A. gossypii strains free of exogenous selection markers for industrial applications. With this tool, we were 
able to block the A. gossypii’s de novo pyrimidine biosynthetic pathway and thus generate a uridine/uracil 
(Agura3Δ) auxotrophic strain, which presents improved riboflavin production under limited uracil/uridine 
supplementation. 
While characterizing the different A. gossypii strains (wild and engineered) we have worked with, we have 
also gathered important information on the physiology of this fungus (e.g., in defined media and in raw 
substrates such as crude glycerol), which have helped us design strategies to improve its performance, 
namely improved tolerance to osmotic stress. 
These results allowed a considerable advance in the understanding of the biotechnological potential of 
A. gossypii and the production of other metabolites of interest is now being rationally evaluated. To 
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